Skip to main navigation Skip to search Skip to main content

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

  • KConFab
  • , The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)
  • , EMBRACE
  • , GEMO Study Collaboratorsz
  • , Australian Ovarian Cancer Study Groupz
  • Centre for Cancer Genetic Epidemiology
  • Keck School of Medicine of USC
  • Cedars-Sinai Medical Center
  • University of Cambridge
  • Queensland Institute of Medical Research
  • Xiamen University
  • Dana-Farber Cancer Institute
  • Helsinki University Hospital
  • University of Toronto
  • University of California at Irvine
  • German Cancer Research Center
  • MD Anderson Cancer Center
  • Karolinska Institutet
  • Rutgers Cancer Institute of New Jersey
  • European Institute of Oncology
  • Department of Pathology
  • Friedrich-Alexander University Erlangen-Nürnberg
  • Centro de Investigación en Red de Enfermedades Raras
  • Duke University
  • Memorial Sloan-Kettering Cancer Center
  • University of Bergen
  • Vanderbilt University
  • International Epidemiology Institute
  • Hannover Medical School
  • University of Southern Denmark
  • University of Copenhagen
  • Copenhagen University Hospital – Herlev and Gentofte
  • Oslo University Hospital-Radiumhospitalet
  • University of Oslo
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
  • University of Tübingen
  • International Agency for Research on Cancer
  • Cancer Council Victoria
  • Institute Catala Oncologia
  • National University Health System
  • Heidelberg University 
  • University of Helsinki
  • University of Utah School of Medicine
  • Hospital Clinico San Carlos
  • Peter Maccallum Cancer Centre
  • Roswell Park Cancer Institute
  • University of Hamburg
  • Université Laval Research Center
  • Seoul National University Cancer Research Institute
  • Seoul National University
  • Ghent University Hospital
  • University of New Mexico
  • University of Sheffield
  • Harvard T.H. Chan School of Public Health
  • Harvard University
  • Pomeranian Medical University in Szczecin
  • Fox Chase Cancer Center
  • Centre de Recherche en Cancérologie de Lyon
  • Maria Sklodowska-Curie Institute of Oncology
  • Leiden University
  • Vall d'Hebron University Hospital
  • Dartmouth College
  • University of Pennsylvania Health System
  • University of Pretoria
  • Research Center
  • Uppsala University
  • Lund University
  • Rigshospitalet
  • Leipzig University
  • University of Manchester
  • University of California at Los Angeles
  • National Cancer Institute (NCI)
  • Institute of Cancer Research
  • Masaryk University
  • Demokritos National Centre for Scientific Research
  • McGill University
  • University of Kansas
  • The Gertner Institute
  • University of Pisa
  • University College London
  • Centre for Epidemiology and Biostatistics
  • Beatson Oncology Centre
  • McGill University Health Centre, Royal Victoria Hospital
  • Huntsman Cancer Institute
  • Mayo Clinic Rochester, MN
  • Institut national de la santé et de la recherche médicale
  • APHP – Paris Saclay University
  • National University of Singapore
  • University of Malaya
  • Sime Darby Medical Centre
  • Kliniken Essen-Mitte
  • Dr. Horst Schmidt Klinik GmbH
  • Beckman Research Institute of City of Hope
  • Danish Cancer Society
  • Netherlands Cancer Institute
  • Erasmus MC Cancer Institute
  • NorthShore University HealthSystem
  • N.N. Petrov Institute of Oncology
  • Georgetown University
  • Aichi Cancer Center Hospital and Research Institute
  • State Research Institute Centre for Innovative Medicine
  • Cancer Prevention Institute of California
  • Radboud University Nijmegen
  • University of Eastern Finland
  • Oslo University Hospital
  • Hong Kong Sanatorium & Hospital
  • The University of Hong Kong
  • Flanders Institute for Biotechnology
  • KU Leuven
  • University of Warwick
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • University of Hawaii Cancer Center
  • Kyushu University
  • Alfred Health
  • University of Glasgow
  • Technical University of Munich
  • IRCCS Istituto Oncologico Veneto - Padova
  • University Health Network
  • University of Texas Health Science Center at Houston
  • University of California at San Francisco
  • National Institute of Oncology
  • The University of Chicago
  • Ohio State University
  • Centre for Biomedical Research on Rare Diseases (CIBERER)
  • Oregon Health and Science University
  • FIRC Institute of Molecular Oncology
  • Medical University of Vienna
  • Moffitt Cancer Center
  • Channing Division of Network Medicine
  • Northern Finland Laboratory Centre NordLab
  • University of Oulu
  • Shaukat Khanum Memorial Cancer Hospital and Research Centre
  • Carmel Medical Center and Technion Faculty of Medicine
  • Center for Integrated Oncology
  • Yale University
  • Fred Hutchinson Cancer Research Center
  • University of Washington
  • The National Cancer Institute
  • Guy’s Hospital
  • Duke Cancer Institute
  • Antoni van Leeuwenhoek Hospital
  • University of Cologne
  • Academia Sinica Taiwan HQ
  • China Medical University Taichung
  • Stanford University School of Medicine
  • Hospices Civils de LyonCentre Léon Bérard
  • University of Melbourne
  • Linköping University
  • INSERM U830
  • Institut Curie
  • Université Paris Cité
  • North Region Cancer Registry, Portuguese Oncology Institute
  • University of Porto
  • Columbia University
  • Odense University Hospital
  • University of Insubria
  • Latvian Biomedical Research and Study Centre
  • University of Oxford
  • Beth Israel Deaconess Medical Center
  • Erasmus University Rotterdam
  • University Hospitals Leuven
  • Ulm University
  • Tri-Service General Hospital
  • Shanghai Center for Disease Control and Prevention
  • Imperial College London
  • Westmead Millennium Institute for Medical Research
  • Université de Franche-Comté
  • Centre Georges-François Leclerc
  • Hôtel Dieu Centre Hospitalier
  • University of Auvergne
  • Centre Georges-François Leclerc
  • CHU de Grenoble
  • Centre Oscar Lambret
  • Dupuytren University Hospital
  • Hôpital Édouard Herriot
  • Centre Léon Bérard
  • Institut Paoli Calmettes
  • CHU Montpellier
  • Université de Lorraine
  • Saint Herblain
  • Centre Antoine Lacassagne
  • PSL Research University
  • CHU Pitie-Salpetriere
  • Hôpital Nord, CHU de Saint-Étienne
  • Institut Claudius Regaud
  • Centre Hospitalier Régional Universitaire de Tours
  • Institut Gustave-Roussy
  • University of Aberdeen
  • Queen's University Belfast
  • University Hospitals Bristol and Weston NHS Foundation Trust
  • Cardiff & Vale University Health Board
  • Trinity College Dublin
  • St James's Hospital
  • NHS Lothian
  • Kennedy-Galton Centre
  • University Hospitals of Leicester NHS Trust
  • Alder Hey Children's NHS Foundation Trust
  • Manchester University NHS Foundation Trust
  • Great Ormond Street Hospital for Children NHS Foundation Trust
  • Nottingham University Hospitals NHS Trust
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Oxford University Hospitals NHS Foundation Trust
  • Sheffield Children's NHS Foundation Trust
  • University of London
  • Singleton Hospital
  • Betsi Cadwaladr University Health Board
  • Utrecht University
  • Amsterdam University Medical Centers
  • VU University Medical Center Amsterdam
  • Maastricht University
  • University of Groningen
  • Netherlands Comprehensive Cancer Organization (IKNL)
  • The Nationwide Network and Registry of Histo- and Cytopathology (PALGA)
  • Westmead Hospital
  • Royal Melbourne Hospital
  • University of Sydney

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Abstract

A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify 13 candidate causal SNPs associated with serous OC (P=9.2 × 10-20), ER-negative BC (P=1.1 × 10-13), BRCA1-associated BC (P=7.7 × 10-16) and triple negative BC (P-diff=2 × 10-5). Genotype-gene expression associations are identified for candidate target genes ANKLE1 (P=2 × 10-3) and ABHD8 (P<2 × 10-3). Chromosome conformation capture identifies interactions between four candidate SNPs and ABHD8, and luciferase assays indicate six risk alleles increased transactivation of the ADHD8 promoter. Targeted deletion of a region containing risk SNP rs56069439 in a putative enhancer induces ANKLE1 downregulation; and mRNA stability assays indicate functional effects for an ANKLE1 3′-UTR SNP. Altogether, these data suggest that multiple SNPs at 19p13 regulate ABHD8 and perhaps ANKLE1 expression, and indicate common mechanisms underlying breast and ovarian cancer risk.

Original languageEnglish
Article number12675
JournalNature Communications
Volume7
DOIs
StatePublished - 07 Sep 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus'. Together they form a unique fingerprint.

Cite this